Home » Newsletters » BioWorld Science

BioWorld Science

March 24, 2016

View Archived Issues

Profounda announces launch of Impavido in the U.S.

Thomson Reuters Drug News Publication Holidays

Regen BioPharma submits IND application for tCellVax to the FDA

Bayer Schering Pharma patents AKR1C3 inhibitors

Novartis discloses Raf kinase C and B inhibitors

Chiesi Farmaceutici develops PI3K inhibitors

GlaxoSmithKline divulges Ret inhibitors

Initiation of phase II study evaluating AGS-003 for the treatment of NSCLC

Boehringer Ingelheim Pharma reports DPP-I inhibitors

BioLineRx starts phase II trial for BL-8040 as novel stem cell mobilization treatment

Novel targets and animal models presented at EAU

First subject dosed in phase Ia healthy volunteer study evaluating SNS-062

Host cell protein complex identified as a potential HBV therapy target

Bio-Path and UT Southwestern enter SLE research agreement

Bristol-Myers Squibb to acquire Padlock Therapeutics

Ultragenyx and Saint Louis University to develop muscular dystrophy treatments

RMC-035, a novel drug candidate for treating pre-eclampsia

Novel liver-directed glucokinase activator discovered at Advinus

OncoTherapy confirms positive phase I results for OTSA-101

ITM Isotopen Technologien Munchen and Scil Proteins partner on targeted radio conjugates

Agilis Biotherapeutics and T-TOP Clinical Research to collaborate on AADC deficiency gene therapy

FDA approves Cinqair injection

Vernalis presents Chk1 inhibitor VER-250840

Roche submits Elecsys BRAHMS PCT sepsis assay to the FDA

Swedish Orphan Biovitrum becomes marketing authorisation holder of efmoroctocog alfa in the E.U.

Eisai withdraws NDA for ultra-high dose mecobalamin in Japan

Phase IIb trial of NTCELL for Parkinson's disease underway in New Zealand

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 11, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...